The Global Market for Stem Cells

NEW YORK, May 25, 2016 /PRNewswire/ -- This BCC Research report provides implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and important national markets. Sales forecasts are provided from 2016 through 2021.

Use this report to:

Quantify and qualify the stem cell research market for prescription drug products.Receive information about implications of stem cell research and commercial trends.Understand how the regulatory environment, healthcare policies, demographics, and other factors directly affect the stem cell-related drug market.Learn about the nature and structure of the stem cell industry along with profiles of the leading companies.

Highlights</b<

The global stem cell market reached over $5.9 billion in 2015 and will grow from about $6.7 billion in 2016 to nearly $12.3 billion in 2021, registering a compound annual growth rate (CAGR) of 13.1% from 2016 through 2021.The Americas stem cell market should reach $2.3 billion in 2016 and $4.1 billion by 2021, with a CAGR of 12.1% through 2021.The Asian stem cell market should reach $1.5 billion in 2016 and $2.9 billion in 2021 at a CAGR of 14.2% through 2021.

STUDY GOALS AND OBJECTIVES

The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products.Important trends are identified and sales forecasts by product categories and major country markets are provided through 2021; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the stem cell–related drug market.The wider economic environment is also taken into account.The report examines strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market.

REASONS FOR DOING THE STUDY

Although products based on stem cells do not yet form an established market, unlike some other potential applications of bioscience, stem cell technology has already produced a number of significant products in important therapeutic areas. This is because the possibilities for successful stem cell therapy are almost beyond estimation, and the urgent need to develop this field is overriding the established, step-by-step approach to proceeding from basic science to practical applications. The potential scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its practical applications so far, evaluate the participating companies and look to its future.

SCOPE OF REPORT

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.